Skip to main content

Table 2 Description of the health antecedents of participants in the baseline

From: Preoperative walking recommendation for non-cardiac surgery patients to reduce the length of hospital stay: a randomized control trial

Medical antecedents Intervention
(n = 249)
Control
(n = 119)
p value
Family health history, n (%)    
 Arterial hypertension 125 (50.2) 59 (49.6) 0.911
 Diabetes 90 (36.1) 31 (26.1) 0.054
 Dyslipidemia 67 (26.9) 27 (22.7) 0.385
 Arrhythmia 20 (8.0) 5 (4.2) 0.172
 Peripheral vascular disease 42 (16.9) 15 (12.6) 0.290
 Transient ischemic attack 9 (3.6) 5 (4.2) 0.776
 Cerebral vascular disease 29 (11.7) 9 (7.6) 0.229
 Myocardial infarction 68 (27.3) 24 (20.2) 0.139
 COPD 15 (6.0) 10 (8.4) 0.396
 Active cancer 98 (39.4) 53 (44.5) 0.345
Cardiovascular risk, n (%)    
 Current smoking 7 (2.8) 6 (5.0) 0.365
 Arterial hypertension 93 (37.4) 44 (37.0) 0.945
 Dyslipidemia 46 (18.5) 23 (19.3) 0.844
 Diabetes mellitus 22 (8.8) 8 (6.7) 0.488
Cardiovascular disease, n (%)    
 Arrhythmia 13 (5.2) 6 (5.0) 0.942
 Peripheral vascular disease 29 (11.7) 12 (10.1) 0.656
 Transient ischemic attack 4 (1.6) 4 (3.4) 0.279
 Cerebral vascular disease 0 (0.0) 1 (0.8) 0.323
 Myocardial infarction 9 (3.6) 3 (2.5) 0.758
Other comorbidities, n (%)    
 COPD 4 (1.6) 2 (1.7) 1.000
 Cancer 53 (21.3) 38 (31.9) 0.027
 Total prior surgeries 2.0 [3.0] 2.0 [2.0] 0.066
Medications taken chronically before surgery, n (%)    
 Antihypertensive 93 (37.4) 46 (38.7) 0.809
 Beta-blocker 16 (6.4) 12 (10.1) 0.216
 Statins 50 (20.1) 17 (14.3) 0.179
 Diuretics 10 (4.0) 11 (9.2) 0.043
 Gastric mucosal protectors 20 (8.0) 11 (9.2) 0.695
 Prophylactic antithrombotic agent 27 (10.8) 17 (14.3) 0.341
  1. Values in each cell correspond to means (standard deviation), counts (proportions), or median [interquartile range]
  2. COPD Chronic obstructive pulmonary disease, NSAI non-steroidal anti-inflammatory